Steward Partners Investment Solutions’s Novo Nordisk NVO Stock Holding History

Steward Partners Investment Solutions’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	$318K	Buy	+2,475	New	+$295K	0.05%	203

Other funds holding NVO

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $42.5B AUM 18.19% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Steward Partners Investment Solutions's NVO Position: Q1 2024 in Review

Steward Partners Investment Solutions opened a new position in Novo Nordisk (NVO) in Q1 2024: 2,475 shares worth $318K. The stake represents 0.05% of the portfolio and ranks #203 among its holdings.

1,747 funds tracked by Wall St. Rank hold NVO as of Q1 2024.

Steward Partners Investment Solutions held 2,475 shares of Novo Nordisk worth $318K as of Q1 2024.
Novo Nordisk was a new Steward Partners Investment Solutions position in Q1 2024.
Novo Nordisk made up 0.05% of Steward Partners Investment Solutions's portfolio in Q1 2024, its #203 holding.
1,747 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2024.

Based on Steward Partners Investment Solutions's 13F filing for Q1 2024, filed 15 May 2024.